How is the maximum vertical pocket (MVP) of amniotic fluid measured during a routine obstetric ultrasound in a healthy singleton pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Measure Maximum Vertical Pocket (MVP) in Pregnancy

The maximum vertical pocket (MVP) is measured by identifying the single deepest vertical pocket of amniotic fluid anywhere in the uterus, positioning the ultrasound probe perpendicular to the uterine contour and parallel to the maternal sagittal plane, measuring the maximal vertical depth in centimeters while excluding umbilical cord and fetal parts from the measurement. 1

Technical Measurement Steps

Probe Positioning

  • Position the transabdominal convex probe vertical to the uterine contour of the abdomen and parallel to the maternal sagittal plane 2
  • Scan all areas of the uterus systematically to identify the deepest pocket 1

Measurement Technique

  • Measure the single maximal vertical pocket found anywhere in the uterine cavity 1
  • The measurement represents the vertical depth only (not horizontal width) 1
  • Exclude umbilical cord and fetal parts from the pocket being measured 3

Handling Umbilical Cord in the Pocket

  • If the deepest pocket contains umbilical cord, measure to the cord, not through it 4
  • This approach is superior for detecting low amniotic fluid volumes compared to measuring through the cord 4
  • The pocket should ideally be free of cord and fetal parts for the most accurate assessment 3

Normal Values and Interpretation

Throughout Gestation

  • A single MVP of ≥2 cm is considered normal throughout all of gestation 1, 5
  • This threshold remains constant and does not vary with gestational age 5

Pathologic Thresholds

  • Oligohydramnios: MVP <2 cm 5, 3
  • Polyhydramnios: MVP >8 cm 5, 3

Clinical Advantages of MVP Over AFI

MVP is the preferred method over amniotic fluid index (AFI) because it reduces false-positive oligohydramnios diagnoses by approximately 50% without compromising detection of adverse outcomes. 5, 6

Key Differences

  • MVP produces fewer unnecessary interventions compared to AFI 1, 5
  • More patients are diagnosed with oligohydramnios using AFI, leading to more obstetric interventions without improving perinatal outcomes 1
  • Neither method performs better at preventing intrauterine fetal demise, but MVP avoids overdiagnosis 1, 7

Common Pitfalls to Avoid

  • Do not measure through umbilical cord if it is present in the pocket—measure to the cord instead 4
  • Do not include fetal parts in the measurement 3
  • Do not use AFI as the primary measurement tool as it leads to overdiagnosis 5
  • Do not diagnose oligohydramnios based solely on clinical fundal-height measurements when ultrasound shows normal MVP 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ultrasound estimation of amniotic fluid volume using the largest vertical pocket containing umbilical cord: measure to or through the cord?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2002

Guideline

Single Deepest Vertical Pocket (MVP) as Primary Measure of Amniotic Fluid at 28 Weeks Gestation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Borderline Amniotic Fluid Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amniotic Fluid Index Measurement and Clinical Significance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.